{"transactions":[{"id":695698,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Series I Warrants","published_at":"2026-08-05T20:16:33.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":879999,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":1027717,"derivative":{"exercise_date":"2026-08-03","expiration_date":"2031-08-03","underlying":"Common Stock","underlying_shares":879999},"source":{"system":"sec-edgar","filing":"0001437749-26-025929","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025929/rdgdoc.xml","form_type":"4"}},{"id":695697,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-08-05T20:16:33.000Z","date":"2026-08-03","kind":"purchase","planned":false,"acquired":true,"shares":293333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On August 3, 2026, the reporting person acquired 293,333 shares of common stock and Series I warrants to purchase 879,999 shares of common stock at a combined purchase price of $0.75 per one share of common stock and three accompanying warrants in a public offering."}],"balance_after":305673,"source":{"system":"sec-edgar","filing":"0001437749-26-025929","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926025929/rdgdoc.xml","form_type":"4"}},{"id":727612,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":false,"shares":174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 693 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":147718,"derivative":{"underlying":"Common Stock","underlying_shares":174},"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727611,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":false,"shares":109,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 434 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"Includes 100,003 shares of common stock underlying Series E warrants to purchase common stock."}],"balance_after":147892,"derivative":{"underlying":"Common Stock","underlying_shares":109},"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727610,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":41,"price":3.12,"value":127.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":12340,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727609,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-22","kind":"exercise","planned":false,"acquired":true,"shares":174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12381,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727608,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":31,"price":2.88,"value":89.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":12207,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":727607,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-06-25T01:00:21.000Z","date":"2026-06-20","kind":"exercise","planned":false,"acquired":true,"shares":109,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12238,"source":{"system":"sec-edgar","filing":"0001437749-26-021610","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774926021610/rdgdoc.xml","form_type":"4"}},{"id":890284,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-20T21:03:23.000Z","date":"2026-02-18","kind":"other","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the voluntary forfeiture for no value received by the reporting person of options to purchase shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":1440000,"exercise_date":"2022-05-19","expiration_date":"2031-05-19","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001683168-26-001214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316826001214/ownership.xml","form_type":"4"}},{"id":890283,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-20T21:03:23.000Z","date":"2026-02-18","kind":"other","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the voluntary forfeiture for no value received by the reporting person of options to purchase shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":2232000,"exercise_date":"2023-07-26","expiration_date":"2033-07-26","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001683168-26-001214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316826001214/ownership.xml","form_type":"4"}},{"id":890282,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-20T21:03:23.000Z","date":"2026-02-18","kind":"other","planned":false,"acquired":false,"shares":2,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents the voluntary forfeiture for no value received by the reporting person of options to purchase shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":993600,"exercise_date":"2024-07-12","expiration_date":"2034-07-12","underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0001683168-26-001214","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316826001214/ownership.xml","form_type":"4"}},{"id":998857,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Performance Based Restricted Stock Units","published_at":"2025-11-14T21:08:22.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":400000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On November 12, 2025, the Board approved this performance based restricted stock unit. The performance based restricted stock units set forth in this table will vest in 20% installments upon the achievement of certain clinical milestones; provided that upon a change of control (as defined in the 2024 Stock Plan) 100% shall vest."}],"balance_after":2017695,"derivative":{"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001437749-25-035184","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035184/rdgdoc.xml","form_type":"4"}},{"id":998856,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"EVP & CFO"}}],"security":"Stock option (right to buy)","published_at":"2025-11-14T21:08:22.000Z","date":"2025-11-12","kind":"grant","planned":false,"acquired":true,"shares":600000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1617695,"derivative":{"exercise_price":0.49,"expiration_date":"2035-11-12","underlying":"Common Stock","underlying_shares":600000},"source":{"system":"sec-edgar","filing":"0001437749-25-035184","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925035184/rdgdoc.xml","form_type":"4"}},{"id":1005797,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":20625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 4, 2024, the reporting person was granted 82,500 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1017695,"derivative":{"underlying":"Common Stock","underlying_shares":20625},"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1005796,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":false,"shares":5023,"price":0.497,"value":2496.431,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":303189,"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1005795,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-11-07T01:24:26.000Z","date":"2025-11-04","kind":"exercise","planned":false,"acquired":true,"shares":20625,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":308212,"source":{"system":"sec-edgar","filing":"0001437749-25-033682","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925033682/rdgdoc.xml","form_type":"4"}},{"id":1083924,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options (right to buy)","published_at":"2025-07-22T01:47:08.000Z","date":"2025-07-17","kind":"grant","planned":false,"acquired":true,"shares":10000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued by the Issuer in connection with the Reporting Person's service as a director of the Issuer and vest based upon the daily volume weighted average price (\"VWAP\") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were issued by the Issuer in connection with the Reporting Person's service as a director of the Issuer and vest based upon the daily volume weighted average price (\"VWAP\") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan."}],"balance_after":10000,"derivative":{"exercise_price":10,"exercise_date":"2025-07-17","expiration_date":"2035-07-17","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001683168-25-005261","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316825005261/ownership.xml","form_type":"4"}},{"id":1083923,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-22T01:47:08.000Z","date":"2025-07-21","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":10,"value":200000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001683168-25-005261","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316825005261/ownership.xml","form_type":"4"}},{"id":1103771,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Series E Warrants","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":false,"shares":810810,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":1038320,"derivative":{"exercise_price":0.37,"underlying":"Common Stock","underlying_shares":810810},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103770,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":false,"shares":4328,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":227510,"derivative":{"underlying":"Common Stock","underlying_shares":4328},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103769,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":231838,"derivative":{"underlying":"Common Stock","underlying_shares":2711},"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103768,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-23","kind":"purchase","planned":false,"acquired":true,"shares":270270,"price":0.37,"value":99999.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On June 23, 2025, the reporting person acquired 270,270 shares of common stock and Series E warrants to purchase 810,810 shares of common stock at a purchase price of $0.37 per share and accompanying warrants in a public offering. The Series E warrants will be exercisable beginning on the effective date of stockholder approval of the issuance of the shares upon exercise of the Series E warrants and will expire five years from the date of such approval."}],"balance_after":287587,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103767,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1054,"price":0.267,"value":281.418,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":17317,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103766,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-22","kind":"exercise","planned":false,"acquired":true,"shares":4328,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":18371,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103765,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":661,"price":0.267,"value":176.487,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":14043,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1103764,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-23T20:35:31.000Z","date":"2025-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2711,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14704,"source":{"system":"sec-edgar","filing":"0001437749-25-021051","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925021051/rdgdoc.xml","form_type":"4"}},{"id":1106293,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":false,"shares":833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":230684,"derivative":{"underlying":"Common Stock","underlying_shares":833},"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1106292,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":203,"price":0.6852,"value":139.0956,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":11993,"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1106291,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-06-19T01:01:07.000Z","date":"2025-06-16","kind":"exercise","planned":false,"acquired":true,"shares":833,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12196,"source":{"system":"sec-edgar","filing":"0001437749-25-020803","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774925020803/rdgdoc.xml","form_type":"4"}},{"id":1374200,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Performance Based Restricted Stock Units","published_at":"2024-11-07T01:00:49.000Z","date":"2024-10-25","kind":"grant","planned":false,"acquired":true,"shares":19180,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On December 29, 2023, the Board approved this performance based restricted stock unit, subject to shareholder approval of the stock plan. The performance based restricted stock units set forth in this table will vest only upon both (A) the approval of the Plan Amendment by the Company stockholders; and (B) the first of the following to occur: (a) a licensing transaction with a valuation, at the time, in excess of $150 million, which valuation shall be determined by the Board; (b) the filing of a new drug application; or (c) upon a Change in Control (as defined in the Plan), in each case subject to the respective executive officer's continued service with the Company at each such vesting date."}],"balance_after":231517,"derivative":{"expiration_date":"2033-12-29","underlying":"Common Stock","underlying_shares":19180},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1374199,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-11-07T01:00:49.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":82500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":212337,"derivative":{"underlying":"Common Stock","underlying_shares":82500},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1374198,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2024-11-07T01:00:49.000Z","date":"2024-11-04","kind":"grant","planned":false,"acquired":true,"shares":65000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":129837,"derivative":{"exercise_price":2.45,"expiration_date":"2034-11-04","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001437749-24-033704","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924033704/rdgdoc.xml","form_type":"4"}},{"id":1469503,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":false,"shares":4329,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 22, 2023, the reporting person was granted 17,313 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":64837,"derivative":{"underlying":"Common Stock","underlying_shares":4329},"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1469502,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1053,"price":3.74,"value":3938.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":11363,"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1469501,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-25T22:01:53.000Z","date":"2024-06-22","kind":"exercise","planned":false,"acquired":true,"shares":4329,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":12416,"source":{"system":"sec-edgar","filing":"0001437749-24-021198","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924021198/rdgdoc.xml","form_type":"4"}},{"id":1472024,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-21T21:01:28.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":false,"shares":2712,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 10,846 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":69166,"derivative":{"underlying":"Common Stock","underlying_shares":2712},"source":{"system":"sec-edgar","filing":"0001437749-24-020996","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020996/rdgdoc.xml","form_type":"4"}},{"id":1472023,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-21T21:01:28.000Z","date":"2024-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":636,"price":3.78,"value":2404.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":8087,"source":{"system":"sec-edgar","filing":"0001437749-24-020996","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020996/rdgdoc.xml","form_type":"4"}},{"id":1472022,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-21T21:01:28.000Z","date":"2024-06-20","kind":"exercise","planned":false,"acquired":true,"shares":2712,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":8723,"source":{"system":"sec-edgar","filing":"0001437749-24-020996","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020996/rdgdoc.xml","form_type":"4"}},{"id":1475311,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-06-18T21:01:48.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":false,"shares":834,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 3,334 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":71878,"derivative":{"underlying":"Common Stock","underlying_shares":834},"source":{"system":"sec-edgar","filing":"0001437749-24-020664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020664/rdgdoc.xml","form_type":"4"}},{"id":1475310,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-18T21:01:48.000Z","date":"2024-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":196,"price":4.14,"value":811.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":6011,"source":{"system":"sec-edgar","filing":"0001437749-24-020664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020664/rdgdoc.xml","form_type":"4"}},{"id":1475309,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-06-18T21:01:48.000Z","date":"2024-06-16","kind":"exercise","planned":false,"acquired":true,"shares":834,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":6207,"source":{"system":"sec-edgar","filing":"0001437749-24-020664","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774924020664/rdgdoc.xml","form_type":"4"}},{"id":1699479,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-27T12:32:37.000Z","date":"2023-12-26","kind":"purchase","planned":false,"acquired":true,"shares":28986,"price":0.69,"value":20000.34,"ownership":{"direct":true},"balance_after":80556,"source":{"system":"sec-edgar","filing":"0001437749-23-035342","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923035342/rdgdoc.xml","form_type":"4"}},{"id":1829440,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-07-14T20:03:10.000Z","date":"2023-07-12","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":376250,"derivative":{"exercise_price":0.69,"exercise_date":"2024-07-12","expiration_date":"2033-07-12","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001683168-23-004920","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316823004920/ownership.xml","form_type":"4"}},{"id":1844212,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-26T22:21:20.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":259688,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1090626,"derivative":{"underlying":"Common Stock","underlying_shares":259688},"source":{"system":"sec-edgar","filing":"0001437749-23-018530","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923018530/rdgdoc.xml","form_type":"4"}},{"id":1844211,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2023-06-26T22:21:20.000Z","date":"2023-06-22","kind":"grant","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":830938,"derivative":{"exercise_price":0.6,"expiration_date":"2033-06-22","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001437749-23-018530","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923018530/rdgdoc.xml","form_type":"4"}},{"id":1846510,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-22T23:02:04.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":false,"shares":40667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 162,667 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 20, 2022, the reporting person was granted 162,667 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":680938,"derivative":{"underlying":"Common Stock","underlying_shares":40667},"source":{"system":"sec-edgar","filing":"0001437749-23-018141","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923018141/rdgdoc.xml","form_type":"4"}},{"id":1846509,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-22T23:02:04.000Z","date":"2023-06-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":9676,"price":0.57,"value":5515.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":51570,"source":{"system":"sec-edgar","filing":"0001437749-23-018141","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923018141/rdgdoc.xml","form_type":"4"}},{"id":1846508,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-22T23:02:04.000Z","date":"2023-06-20","kind":"exercise","planned":false,"acquired":true,"shares":40667,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":61246,"source":{"system":"sec-edgar","filing":"0001437749-23-018141","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923018141/rdgdoc.xml","form_type":"4"}},{"id":1849551,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-06-20T22:00:40.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":721605,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001437749-23-017885","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923017885/rdgdoc.xml","form_type":"4"}},{"id":1849550,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-20T22:00:40.000Z","date":"2023-06-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":3044,"price":0.57,"value":1735.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":20579,"source":{"system":"sec-edgar","filing":"0001437749-23-017885","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923017885/rdgdoc.xml","form_type":"4"}},{"id":1849549,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-06-20T22:00:40.000Z","date":"2023-06-16","kind":"exercise","planned":false,"acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":23623,"source":{"system":"sec-edgar","filing":"0001437749-23-017885","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774923017885/rdgdoc.xml","form_type":"4"}},{"id":1949702,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2023-03-16T16:14:58.000Z","date":"2022-07-26","kind":"grant","acquired":true,"shares":101250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":176250,"derivative":{"exercise_price":1.55,"exercise_date":"2023-07-26","expiration_date":"2032-07-26","underlying":"Common stock","underlying_shares":101250},"source":{"system":"sec-edgar","filing":"0001683168-23-001538","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316823001538/ownership.xml","form_type":"4/A","original_submission_date":"2022-08-12"}},{"id":2186625,"issuer":{"id":21,"kind":"organization","name":"Empery Digital Inc.","symbol":"EMPD"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2022-08-12T17:33:54.000Z","date":"2022-07-26","kind":"grant","acquired":true,"shares":101250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":101250,"derivative":{"exercise_price":1.55,"exercise_date":"2023-07-26","expiration_date":"2032-07-26","underlying":"Common stock","underlying_shares":101250},"source":{"system":"sec-edgar","filing":"0001683168-22-005609","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000168316822005609/ownership.xml","form_type":"4"}},{"id":2224121,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-22T23:04:39.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":162667,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one shares of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":734105,"derivative":{"underlying":"Common stock","underlying_shares":162667},"source":{"system":"sec-edgar","filing":"0001437749-22-015664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774922015664/rdgdoc.xml","form_type":"4"}},{"id":2224120,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2022-06-22T23:04:39.000Z","date":"2022-06-20","kind":"grant","acquired":true,"shares":155000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":571438,"derivative":{"exercise_price":1.49,"expiration_date":"2032-06-20","underlying":"Common stock","underlying_shares":155000},"source":{"system":"sec-edgar","filing":"0001437749-22-015664","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774922015664/rdgdoc.xml","form_type":"4"}},{"id":2225441,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-22T00:07:53.000Z","date":"2022-06-16","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 16, 2021, the reporting person was granted 50,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":416438,"derivative":{"underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001437749-22-015535","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774922015535/rdgdoc.xml","form_type":"4"}},{"id":2225440,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-22T00:07:53.000Z","date":"2022-06-16","kind":"tax_withholding","acquired":false,"shares":3044,"price":1.33,"value":4048.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Shares withheld for payment of taxes upon vesting of restricted stock unit awards."}],"balance_after":11123,"source":{"system":"sec-edgar","filing":"0001437749-22-015535","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774922015535/rdgdoc.xml","form_type":"4"}},{"id":2225439,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-22T00:07:53.000Z","date":"2022-06-16","kind":"exercise","acquired":true,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14167,"source":{"system":"sec-edgar","filing":"0001437749-22-015535","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774922015535/rdgdoc.xml","form_type":"4"}},{"id":2465329,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-12-17T22:07:38.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":12500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each outstanding and unexercised warrant, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to the excess of (i) the number of shares of common stock subject to the warrant, multiplied by the Merger Consideration over (ii) the number of shares of common stock subject to the warrant, multiplied by the per share exercise price of such warrant."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2023-10-19","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001548187-21-000074","document":"wf-form4_163977884268775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000154818721000074/wf-form4_163977884268775.xml","form_type":"4"}},{"id":2465328,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:07:38.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":12.94,"expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001548187-21-000074","document":"wf-form4_163977884268775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000154818721000074/wf-form4_163977884268775.xml","form_type":"4"}},{"id":2465327,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:07:38.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":14.62,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001548187-21-000074","document":"wf-form4_163977884268775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000154818721000074/wf-form4_163977884268775.xml","form_type":"4"}},{"id":2465326,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-12-17T22:07:38.000Z","date":"2021-12-16","kind":"disposition_to_issuer","acquired":false,"shares":30000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the \"Merger Agreement\"), by and among Soliton, Inc. (the \"Company\"), AbbVie Inc. (\"AbbVie\") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie (\"Merger Sub\"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the \"Merger\"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the \"Merger Consideration\") minus the exercise price that would be due in cash upon exercise of such option."}],"balance_after":0,"derivative":{"exercise_price":1.75,"expiration_date":"2028-06-19","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001548187-21-000074","document":"wf-form4_163977884268775.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000154818721000074/wf-form4_163977884268775.xml","form_type":"4"}},{"id":2661000,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Exec. Vice President and CFO"}}],"security":"Restricted Stock Units","published_at":"2021-06-21T20:21:16.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units set forth in this table vest in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":428938,"derivative":{"underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001437749-21-015276","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774921015276/rdgdoc.xml","form_type":"4"}},{"id":2660999,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"officer":true,"officer_title":"Exec. Vice President and CFO"}}],"security":"Stock option (right to buy)","published_at":"2021-06-21T20:21:16.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":108770,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest in four equal annual installments, beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":378938,"derivative":{"exercise_price":3.73,"expiration_date":"2031-06-16","underlying":"Common Stock","underlying_shares":108770},"source":{"system":"sec-edgar","filing":"0001437749-21-015276","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000143774921015276/rdgdoc.xml","form_type":"4"}},{"id":3087525,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice President and CFO"}}],"security":"Stock option (right to buy)","published_at":"2020-07-07T21:14:39.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":460000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1621000,"derivative":{"exercise_price":0.928,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001659617-20-000172","document":"wf-form4_159415646381168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000165961720000172/wf-form4_159415646381168.xml","form_type":"4"}},{"id":3101578,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2020-06-23T13:20:59.000Z","date":"2020-06-19","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest one year after issuance, subject to the grantee's continued service on the Company's Board of Directors."}],"balance_after":72500,"derivative":{"exercise_price":12.94,"expiration_date":"2030-06-19","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001548187-20-000066","document":"wf-form4_159291844147774.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000154818720000066/wf-form4_159291844147774.xml","form_type":"4"}},{"id":3461919,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice President and CFO"}}],"security":"Stock option (right to buy)","published_at":"2019-07-15T20:04:42.000Z","date":"2019-07-11","kind":"grant","acquired":true,"shares":315000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(2) Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"(1) The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":1161000,"derivative":{"exercise_price":1.31,"expiration_date":"2029-07-11","underlying":"Common Stock","underlying_shares":315000},"source":{"system":"sec-edgar","filing":"0001659617-19-000101","document":"wf-form4_156322106686428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000165961719000101/wf-form4_156322106686428.xml","form_type":"4"}},{"id":3474362,"issuer":{"id":132212,"kind":"organization","name":"Soliton, Inc.","symbol":"SOLY"},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":true}}],"security":"Stock option (right to buy)","published_at":"2019-07-01T20:31:53.000Z","date":"2019-06-27","kind":"grant","acquired":true,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director service to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest one year after issuance, subject to the grantee's continued service on the Company's Board of Directors."}],"balance_after":57500,"derivative":{"exercise_price":14.62,"expiration_date":"2029-06-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001437749-19-013232","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1545414/000143774919013232/rdgdoc.xml","form_type":"4"}},{"id":3900059,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2018-06-08T21:24:36.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":301000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":846000,"derivative":{"exercise_price":1.82,"expiration_date":"2028-06-06","underlying":"Common stock","underlying_shares":301000},"source":{"system":"sec-edgar","filing":"0001144204-18-033606","document":"tv496090_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000114420418033606/tv496090_4.xml","form_type":"4"}},{"id":4191072,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock option (right to buy)","published_at":"2017-10-05T22:02:40.000Z","date":"2017-10-03","kind":"grant","acquired":true,"shares":145000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option set forth in this table vests in four equal annual installments beginning on the first anniversary of the Transaction Date, subject to the grantee's continued service to the Company on each vesting date."}],"balance_after":545000,"derivative":{"exercise_price":2.49,"expiration_date":"2027-10-03","underlying":"Common stock","underlying_shares":145000},"source":{"system":"sec-edgar","filing":"0001144204-17-051545","document":"v476493_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000114420417051545/v476493_4.xml","form_type":"4"}},{"id":4344615,"issuer":{"id":7886,"kind":"organization","name":"Moleculin Biotech, Inc."},"owners":[{"id":26234,"kind":"person","name":"Foster Jonathan P.","position":1,"cik":"0001545414","reported_name":"Foster Jonathan P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Exec. Vice President & CFO"}}],"security":"Common Stock","published_at":"2017-04-26T20:30:40.000Z","date":"2017-04-25","kind":"purchase","acquired":true,"shares":10000,"price":0.8649,"value":8649.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001144204-17-022289","document":"v465197_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1659617/000114420417022289/v465197_form4.xml","form_type":"4"}}]}